Advanced Enzyme Technologies Limited (ADVENZYMES.NS)
NSE · INR · Basic Materials · Specialty Chemicals
₹260.65 (+3.37%) as of
Key statistics
- Market cap
- 28.44B
- P/E (TTM)
- 17.60
- Forward P/E
- 14.17
- EPS (TTM)
- 14.81
- Dividend yield
- 0.54%
- 52-week range
- 246.80 – 419.00
- Beta
- 0.70
- Revenue (TTM)
- 7.5B
- Profit margin
- 22.13%
- Analyst target
- ₹370.00
- Volume
- 146.45k
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- Thane, India
- Employees
- 409
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.